ANTI-THYMOCYTE GLOBULIN (RABBIT)

ANTI-THYMOCYTE GLOBULIN (RABBIT) was reported 8135 times

ANTI-THYMOCYTE GLOBULIN (RABBIT) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUNG DISEASE INFECTIVE EXACERBATION 12 0.4444
1 BACILLE CALMETTE-GUERIN SCAR REACTIVATION 5 0.4167
2 PROTOTHECOSIS 30 0.3191
3 PANCREATIC PSEUDOANEURYSM 6 0.3158
4 ASPERGILLOSIS ORAL 5 0.2500
5 COMPLICATIONS OF TRANSPLANTED PANCREAS 8 0.2286
6 SLEEP-RELATED BREATHING DISORDER 8 0.2105
7 PYELONEPHRITIS FUNGAL 15 0.2027
8 DELAYED GRAFT FUNCTION 110 0.1547
9 ENCEPHALITIS CYTOMEGALOVIRUS 67 0.1530
10 RETINOPATHY HAEMORRHAGIC 10 0.1515
11 DONOR SPECIFIC ANTIBODY PRESENT 23 0.1494
12 AUTOIMMUNE PANCYTOPENIA 13 0.1429
13 ANORECTAL VARICES 6 0.1429
14 PERINEPHRIC ABSCESS 21 0.1382
15 RENAL GRAFT LOSS 11 0.1358
16 CHIMERISM 12 0.1348
17 HYPERFIBRINOGENAEMIA 9 0.1343
18 HEART TRANSPLANT REJECTION 138 0.1329
19 ENGRAFT FAILURE 37 0.1289
20 GRAFT LOSS 93 0.1283
21 GRAFT VERSUS HOST DISEASE IN INTESTINE 16 0.1231
22 SKIN GRAFT REJECTION 7 0.1228
23 ISOSPORIASIS 9 0.1154
24 PANCREAS TRANSPLANT REJECTION 23 0.1144
25 SEPTAL PANNICULITIS 9 0.1125
26 PROSTHETIC VALVE ENDOCARDITIS 6 0.1071
27 NEW ONSET DIABETES AFTER TRANSPLANTATION 18 0.1040
28 PHARYNGEAL POLYP 9 0.1023
29 CYTOMEGALOVIRUS DUODENITIS 7 0.1000
30 EMPHYSEMATOUS PYELONEPHRITIS 17 0.0929
31 ADENOVIRAL HEPATITIS 21 0.0894
32 EPSTEIN-BARR VIRAEMIA 98 0.0884
33 METAPNEUMOVIRUS PNEUMONIA 8 0.0833
34 RENAL GRAFT INFECTION 19 0.0819
35 CHRONIC ALLOGRAFT NEPHROPATHY 64 0.0817
36 POLYOMAVIRUS VIRAEMIA 86 0.0810
37 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 221 0.0799
38 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 112 0.0793
39 SERUM SICKNESS 217 0.0778
40 ANGIOSARCOMA METASTATIC 9 0.0738
41 GRAFT DYSFUNCTION 21 0.0737
42 BK POLYOMAVIRUS TEST POSITIVE 7 0.0729
43 DISSEMINATED TRICHOSPORONOSIS 5 0.0694
44 AEROMONAS INFECTION 13 0.0688
45 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 49 0.0682
46 URINARY TRACT CANDIDIASIS 13 0.0681
47 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 118 0.0667
48 BK VIRUS INFECTION 220 0.0652
49 COMPLICATIONS OF TRANSPLANTED KIDNEY 147 0.0648
50 CYTOMEGALOVIRUS TEST POSITIVE 115 0.0645
51 COLITIS EROSIVE 10 0.0629
52 INTESTINE TRANSPLANT REJECTION 6 0.0625
53 GENITAL HERPES SIMPLEX 13 0.0613
54 MUCOSAL HYPERTROPHY 9 0.0608
55 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 142 0.0606
56 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 18 0.0604
57 PARVOVIRUS B19 INFECTION 53 0.0592
58 URINOMA 9 0.0570
59 TRANSPLANT REJECTION 454 0.0566
60 ACUTE GRAFT VERSUS HOST DISEASE 257 0.0561
61 INTRACRANIAL INFECTION 7 0.0560
62 ENTEROCOLITIS VIRAL 17 0.0559
63 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS 5 0.0538
64 CARDIAC VALVE ABSCESS 5 0.0538
65 RENAL TRANSPLANT FAILURE 53 0.0536
66 LATENT AUTOIMMUNE DIABETES IN ADULTS 9 0.0526
67 ACUTE MYELOID LEUKAEMIA RECURRENT 112 0.0521
68 TOOTH HYPOPLASIA 9 0.0517
69 BRONCHIOLITIS OBLITERANS SYNDROME 9 0.0514
70 CYTOMEGALOVIRUS GASTROENTERITIS 11 0.0509
71 ACUTE CHOLECYSTITIS NECROTIC 10 0.0498
72 STENOTROPHOMONAS SEPSIS 6 0.0496
73 WEST NILE VIRAL INFECTION 37 0.0493
74 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 7 0.0490
75 ASPERGILLUS TEST POSITIVE 15 0.0487
76 ADENOVIRUS REACTIVATION 7 0.0486
77 RETICULOCYTOPENIA 7 0.0479
78 CHRONIC GRAFT VERSUS HOST DISEASE 170 0.0470
79 IDIOPATHIC PNEUMONIA SYNDROME 14 0.0470
80 CYTOMEGALOVIRUS INFECTION REACTIVATION 204 0.0461
81 KIDNEY TRANSPLANT REJECTION 220 0.0458
82 GRAFT THROMBOSIS 12 0.0458
83 CRYPTOCOCCAL MENINGOENCEPHALITIS 6 0.0458
84 MALIGNANT FIBROUS HISTIOCYTOMA 6 0.0444
85 POST TRANSPLANT DISTAL LIMB SYNDROME 9 0.0443
86 PARVOVIRUS INFECTION 17 0.0421
87 BLOOD STEM CELL TRANSPLANT FAILURE 9 0.0419
88 DISSEMINATED CYTOMEGALOVIRAL INFECTION 9 0.0417
89 PULMONARY MUCORMYCOSIS 22 0.0417
90 TRANSPLANT FAILURE 100 0.0407
91 CYTOMEGALOVIRUS VIRAEMIA 179 0.0402
92 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 201 0.0395
93 PNEUMONIA CYTOMEGALOVIRAL 76 0.0391
94 RENAL ARTERY THROMBOSIS 12 0.0388
95 KLEBSIELLA URINARY TRACT INFECTION 10 0.0377
96 COMPLICATIONS OF TRANSPLANT SURGERY 19 0.0376
97 ENGRAFTMENT SYNDROME 22 0.0372
98 SCEDOSPORIUM INFECTION 26 0.0368
99 CYTOMEGALOVIRUS ENTERITIS 13 0.0365
100 CYTOMEGALOVIRUS SYNDROME 6 0.0364
101 ADENOVIRUS INFECTION 105 0.0362
102 CYSTITIS HAEMORRHAGIC 143 0.0354
103 EYE INFECTION TOXOPLASMAL 14 0.0353
104 INTERLEUKIN-2 RECEPTOR INCREASED 6 0.0351
105 ENAMEL ANOMALY 10 0.0350
106 SCROTAL ULCER 9 0.0345
107 SPLENIC ABSCESS 14 0.0344
108 EPSTEIN-BARR VIRUS INFECTION 215 0.0344
109 RENAL CORTICAL NECROSIS 8 0.0343
110 MICROSPORIDIA INFECTION 12 0.0342
111 TRICHODYSPLASIA SPINULOSA 13 0.0341
112 VIRAL HAEMORRHAGIC CYSTITIS 24 0.0337
113 CERVICITIS 15 0.0336
114 COMPLICATIONS OF BONE MARROW TRANSPLANT 12 0.0332
115 LYMPHOCELE 22 0.0331
116 CUTANEOUS TUBERCULOSIS 6 0.0330
117 T-LYMPHOCYTE COUNT INCREASED 6 0.0323
118 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0316
119 ANAEMIA HAEMOLYTIC AUTOIMMUNE 26 0.0314
120 MORGANELLA INFECTION 9 0.0307
121 MALACOPLAKIA 14 0.0306
122 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 7 0.0302
123 CANDIDA SEPSIS 27 0.0301
124 CEREBRAL TOXOPLASMOSIS 28 0.0300
125 GRAFT VERSUS HOST DISEASE IN SKIN 66 0.0299
126 VESICOURETERIC REFLUX 12 0.0296
127 CAPILLARITIS 8 0.0290
128 INFECTION REACTIVATION 33 0.0288
129 CYSTITIS VIRAL 11 0.0287
130 HUMAN EHRLICHIOSIS 6 0.0287
131 GRAFT VERSUS HOST DISEASE 206 0.0286
132 ABSCESS FUNGAL 5 0.0286
133 ENTEROCOCCAL SEPSIS 23 0.0284
134 CITROBACTER INFECTION 12 0.0280
135 COMPLICATIONS OF TRANSPLANTED HEART 6 0.0279
136 CYTOMEGALOVIRUS INFECTION 453 0.0272
137 CYTOMEGALOVIRUS OESOPHAGITIS 10 0.0272
138 AMERICAN TRYPANOSOMIASIS 7 0.0259
139 TRANSPLANT DYSFUNCTION 46 0.0258
140 CORONA VIRUS INFECTION 11 0.0256
141 SYSTEMIC CANDIDA 64 0.0255
142 DISSEMINATED MUCORMYCOSIS 10 0.0254
143 VENOOCCLUSIVE DISEASE 62 0.0247
144 RED BLOOD CELL SCHISTOCYTES PRESENT 8 0.0247
145 BURKHOLDERIA CEPACIA COMPLEX INFECTION 7 0.0245
146 LIVER TRANSPLANT REJECTION 43 0.0239
147 RENAL TUBULAR ATROPHY 21 0.0238
148 VIRAEMIA 33 0.0238
149 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 11 0.0236
150 HUMAN HERPESVIRUS 6 INFECTION 43 0.0227
151 LUNG TRANSPLANT REJECTION 15 0.0227
152 BONE MARROW TRANSPLANT REJECTION 5 0.0227
153 GRAFT VERSUS HOST DISEASE IN LIVER 16 0.0223
154 MUCORMYCOSIS 58 0.0223
155 ENCEPHALITIS VIRAL 27 0.0222
156 ANTITHROMBIN III DECREASED 6 0.0220
157 THROMBOTIC MICROANGIOPATHY 212 0.0217
158 TOXOPLASMOSIS 23 0.0213
159 BACTERIURIA 12 0.0212
160 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 11 0.0210
161 ARTHRITIS REACTIVE 13 0.0208
162 CYTOMEGALOVIRUS ENTEROCOLITIS 16 0.0208
163 PNEUMONIA ESCHERICHIA 7 0.0206
164 BLASTOMYCOSIS 10 0.0206
165 T-LYMPHOCYTE COUNT DECREASED 14 0.0205
166 VIRAL DIARRHOEA 7 0.0203
167 EXTRAPULMONARY TUBERCULOSIS 6 0.0203
168 NEUTROPHILIC DERMATOSIS 8 0.0203
169 HAEMOLYTIC URAEMIC SYNDROME 45 0.0194
170 URINARY TRACT INFECTION ENTEROCOCCAL 18 0.0193
171 ASPERGILLOSIS 25 0.0191
172 BACTERIAL ENDOPHTHALMITIS 5 0.0188
173 MEASLES 10 0.0186
174 URINARY TRACT INFECTION PSEUDOMONAL 11 0.0183
175 INFECTIVE ANEURYSM 9 0.0182
176 PROTEUS INFECTION 13 0.0181
177 MENINGOENCEPHALITIS HERPETIC 8 0.0179
178 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 38 0.0178
179 CRYPTOCOCCOSIS 29 0.0178
180 HEPATITIS C RNA INCREASED 6 0.0175
181 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 28 0.0175
182 CRYPTOSPORIDIOSIS INFECTION 9 0.0171
183 GINGIVAL HYPERTROPHY 26 0.0171
184 PSEUDOMONAL SEPSIS 30 0.0171
185 LICHENIFICATION 7 0.0170
186 HEPATITIS C VIRUS TEST POSITIVE 10 0.0170
187 KLEBSIELLA INFECTION 86 0.0170
188 COAGULATION TEST ABNORMAL 13 0.0169
189 KLEBSIELLA SEPSIS 19 0.0169
190 PNEUMOCYSTIS JIROVECII INFECTION 20 0.0167
191 COMPLICATIONS OF TRANSPLANTED LIVER 6 0.0167
192 TRANSPLANTATION COMPLICATION 7 0.0167
193 CYTOMEGALOVIRUS COLITIS 38 0.0165
194 GASTROENTERITIS ESCHERICHIA COLI 9 0.0165
195 CYTOMEGALOVIRUS CHORIORETINITIS 32 0.0164
196 BRONCHOPULMONARY ASPERGILLOSIS 127 0.0164
197 NEUROENDOCRINE CARCINOMA OF THE SKIN 16 0.0163
198 ENCEPHALITIS HERPES 8 0.0162
199 BRAIN ABSCESS 41 0.0162
200 VENOOCCLUSIVE LIVER DISEASE 80 0.0162
201 HAPTOGLOBIN DECREASED 13 0.0161
202 KIDNEY FIBROSIS 28 0.0161
203 CONGENITAL APLASIA 5 0.0161
204 EPSTEIN-BARR VIRUS TEST POSITIVE 10 0.0158
205 GLOMERULOSCLEROSIS 10 0.0158
206 PULMONARY NOCARDIOSIS 13 0.0158
207 HERPES SIMPLEX REACTIVATION 6 0.0157
208 REACTIVE GASTROPATHY 6 0.0157
209 OPERATIVE HAEMORRHAGE 7 0.0157
210 ABDOMINAL WALL ABSCESS 10 0.0154
211 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 20 0.0152
212 CAMPYLOBACTER GASTROENTERITIS 9 0.0152
213 PARAINFLUENZAE VIRUS INFECTION 23 0.0151
214 ZYGOMYCOSIS 7 0.0150
215 ENTEROCOCCAL INFECTION 72 0.0149
216 BACTERIAL PYELONEPHRITIS 5 0.0149
217 STRONGYLOIDIASIS 24 0.0148
218 TRICHOSPORON INFECTION 6 0.0148
219 HISTIOCYTOSIS HAEMATOPHAGIC 44 0.0148
220 STEM CELL TRANSPLANT 37 0.0148
221 HUMAN HERPESVIRUS 8 INFECTION 9 0.0148
222 KLEBSIELLA BACTERAEMIA 14 0.0147
223 RENAL ISCHAEMIA 8 0.0146
224 CANDIDA TEST POSITIVE 6 0.0144
225 SMOOTH MUSCLE CELL NEOPLASM 6 0.0144
226 ENTEROCOCCAL BACTERAEMIA 15 0.0142
227 URINARY TRACT INFECTION STAPHYLOCOCCAL 6 0.0141
228 CHORIORETINITIS 9 0.0140
229 ACINETOBACTER INFECTION 15 0.0137
230 METASTATIC SQUAMOUS CELL CARCINOMA 7 0.0137
231 ENTEROBACTER INFECTION 23 0.0137
232 RENAL HAEMATOMA 7 0.0136
233 STAPHYLOCOCCAL SEPSIS 67 0.0136
234 ANASTOMOTIC STENOSIS 5 0.0134
235 RENAL TUBULAR NECROSIS 131 0.0133
236 NOCARDIOSIS 34 0.0133
237 CAMPYLOBACTER INFECTION 11 0.0132
238 RENAL ARTERY STENOSIS 18 0.0131
239 PROCEDURAL HYPOTENSION 11 0.0129
240 STAPHYLOCOCCAL BACTERAEMIA 56 0.0129
241 GRAFT VERSUS HOST DISEASE IN LUNG 6 0.0126
242 LUNG INFECTION PSEUDOMONAL 7 0.0125
243 INFECTION IN AN IMMUNOCOMPROMISED HOST 9 0.0125
244 APLASIA PURE RED CELL 43 0.0125
245 RENAL TUBULAR INJURY 15 0.0123
246 EVANS SYNDROME 6 0.0122
247 ENDOCARDITIS STAPHYLOCOCCAL 6 0.0122
248 SEPTIC EMBOLUS 10 0.0120
249 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 11 0.0119
250 CENTRAL SEROUS CHORIORETINOPATHY 8 0.0117
251 SKIN TOXICITY 66 0.0117
252 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 38 0.0115
253 HYPHAEMA 6 0.0115
254 MENINGITIS CRYPTOCOCCAL 20 0.0114
255 OBLITERATIVE BRONCHIOLITIS 15 0.0114
256 HUMAN POLYOMAVIRUS INFECTION 6 0.0113
257 SYSTEMIC MYCOSIS 13 0.0111
258 ESCHERICHIA BACTERAEMIA 26 0.0110
259 GLOMERULONEPHRITIS 27 0.0110
260 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 28 0.0108
261 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 13 0.0108
262 TRANSITIONAL CELL CARCINOMA 14 0.0108
263 CAPILLARY LEAK SYNDROME 22 0.0106
264 ESCHERICHIA SEPSIS 30 0.0103
265 APLASTIC ANAEMIA 54 0.0103
266 MUCOUS MEMBRANE DISORDER 14 0.0102
267 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 8 0.0102
268 HAEMATOLOGICAL INFECTION 25 0.0102
269 HYPERTENSIVE EMERGENCY 12 0.0102
270 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 6 0.0102
271 HISTOPLASMOSIS DISSEMINATED 16 0.0101
272 ESCHERICHIA INFECTION 82 0.0100
273 CLOSTRIDIUM COLITIS 12 0.0099
274 BACTERIAL SEPSIS 32 0.0098
275 GASTROENTERITIS NOROVIRUS 13 0.0098
276 HERPES SIMPLEX 63 0.0097
277 FUNGAL SEPSIS 8 0.0096
278 BACTERAEMIA 114 0.0096
279 URINARY TRACT INFECTION BACTERIAL 24 0.0095
280 NEUTROPENIC INFECTION 9 0.0094
281 HEPATOSPLENOMEGALY 24 0.0093
282 PNEUMONIA INFLUENZAL 11 0.0092
283 KLEBSIELLA TEST POSITIVE 6 0.0092
284 LYMPHOPROLIFERATIVE DISORDER 27 0.0092
285 ASPERGILLUS INFECTION 60 0.0091
286 NEPHROPATHY TOXIC 101 0.0090
287 METAPNEUMOVIRUS INFECTION 7 0.0089
288 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 7 0.0089
289 NORMOCYTIC ANAEMIA 13 0.0088
290 URETERIC STENOSIS 7 0.0087
291 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 8 0.0086
292 FUSARIUM INFECTION 6 0.0086
293 GLOMERULONEPHRITIS MEMBRANOUS 10 0.0085
294 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 81 0.0085
295 NON-HODGKIN'S LYMPHOMA 11 0.0084
296 ORCHITIS 9 0.0084
297 IRON OVERLOAD 9 0.0083
298 NOROVIRUS INFECTION 12 0.0083
299 PYELONEPHRITIS ACUTE 16 0.0082
300 CEREBRAL ASPERGILLOSIS 5 0.0081
301 OSMOTIC DEMYELINATION SYNDROME 6 0.0081
302 PNEUMONIA STAPHYLOCOCCAL 16 0.0081
303 PYURIA 8 0.0081
304 MULTI-ORGAN FAILURE 138 0.0080
305 LYMPHOCYTIC INFILTRATION 8 0.0079
306 DRUG LEVEL FLUCTUATING 7 0.0079
307 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 59 0.0079
308 MYCOPLASMA INFECTION 6 0.0077
309 HYPOGAMMAGLOBULINAEMIA 49 0.0075
310 CLEAR CELL RENAL CELL CARCINOMA 5 0.0072
311 HYPOCHROMIC ANAEMIA 7 0.0069
312 RESPIRATORY TRACT INFECTION VIRAL 16 0.0069
313 PNEUMONIA FUNGAL 27 0.0068
314 ESCHERICHIA URINARY TRACT INFECTION 29 0.0068
315 BLOOD ALBUMIN INCREASED 6 0.0067
316 PNEUMOCYSTIS JIROVECI PNEUMONIA 15 0.0067
317 MICROCYTIC ANAEMIA 14 0.0067
318 GASTROINTESTINAL WALL THICKENING 10 0.0067
319 STENOTROPHOMONAS INFECTION 9 0.0066
320 DISSEMINATED CRYPTOCOCCOSIS 5 0.0066
321 METASTATIC MALIGNANT MELANOMA 15 0.0065
322 LARGE INTESTINE INFECTION 8 0.0065
323 PNEUMOCYSTIS JIROVECII PNEUMONIA 65 0.0065
324 STREPTOCOCCAL BACTERAEMIA 7 0.0064
325 H1N1 INFLUENZA 9 0.0064
326 TINEA INFECTION 7 0.0063
327 NEPHRITIS INTERSTITIAL 8 0.0063
328 CYTOLYTIC HEPATITIS 21 0.0063
329 VARICELLA 15 0.0063
330 ELECTROMECHANICAL DISSOCIATION 5 0.0063
331 DISSEMINATED TUBERCULOSIS 16 0.0062
332 GENERALISED OEDEMA 77 0.0062
333 PSEUDOMONAS INFECTION 53 0.0062
334 APLASIA 12 0.0061
335 OLIGURIA 38 0.0061
336 ACUTE RESPIRATORY DISTRESS SYNDROME 108 0.0061
337 DIFFUSE LARGE B-CELL LYMPHOMA 47 0.0061
338 HYDRONEPHROSIS 45 0.0060
339 SALMONELLOSIS 10 0.0059
340 NEPHROCALCINOSIS 7 0.0059
341 ISCHAEMIC HEPATITIS 8 0.0058
342 LYMPHOPENIA 82 0.0058
343 NON-CARDIOGENIC PULMONARY OEDEMA 6 0.0057
344 RENAL INFARCT 8 0.0055
345 CERVICAL DYSPLASIA 12 0.0055
346 INTRA-ABDOMINAL HAEMORRHAGE 13 0.0055
347 RIGHT VENTRICULAR DYSFUNCTION 6 0.0054
348 CANDIDA INFECTION 91 0.0054
349 PSEUDOMEMBRANOUS COLITIS 12 0.0054
350 BACTERIAL INFECTION 100 0.0054
351 SHOCK HAEMORRHAGIC 42 0.0052
352 SERUM FERRITIN INCREASED 27 0.0051
353 BICYTOPENIA 10 0.0051
354 MULTIPLE ORGAN DYSFUNCTION SYNDROME 144 0.0051
355 PYELONEPHRITIS 44 0.0051
356 PNEUMONIA VIRAL 16 0.0050
357 FEBRILE NEUTROPENIA 332 0.0050
358 CANDIDIASIS 20 0.0050
359 RENAL TRANSPLANT 18 0.0050
360 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0049
361 DISSEMINATED INTRAVASCULAR COAGULATION 69 0.0049
362 PNEUMONIA KLEBSIELLA 9 0.0049
363 VARICELLA ZOSTER VIRUS INFECTION 10 0.0048
364 ANTIBODY TEST POSITIVE 8 0.0048
365 SMALL INTESTINAL PERFORATION 9 0.0048
366 HAEMOLYTIC ANAEMIA 42 0.0047
367 ANURIA 40 0.0046
368 HAEMODIALYSIS 39 0.0046
369 BONE MARROW FAILURE 94 0.0046
370 RHINOVIRUS INFECTION 18 0.0046
371 FUNGAL PERITONITIS 7 0.0046
372 FUNGAEMIA 7 0.0044
373 HEPATITIS E 7 0.0044
374 IDIOPATHIC THROMBOCYTOPENIC PURPURA 7 0.0044
375 RESPIRATORY DISTRESS 121 0.0044
376 PULMONARY HAEMORRHAGE 34 0.0043
377 PANCYTOPENIA 240 0.0043
378 ENDOCARDITIS 22 0.0043
379 PATHOGEN RESISTANCE 39 0.0043
380 HAEMOLYSIS 33 0.0043
381 PAPILLOMA VIRAL INFECTION 7 0.0042
382 SUBCUTANEOUS ABSCESS 20 0.0042
383 TONSILLAR HYPERTROPHY 7 0.0042
384 LEUKAEMIA RECURRENT 7 0.0041
385 ARTERIAL THROMBOSIS 8 0.0041
386 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
387 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 10 0.0040
388 NEPHRECTOMY 6 0.0040
389 PARESIS 9 0.0040
390 PNEUMONIA BACTERIAL 37 0.0040
391 LEUKOPENIA 201 0.0040
392 BLOOD CULTURE POSITIVE 12 0.0040
393 HEPATIC NECROSIS 15 0.0040
394 GASTROINTESTINAL OEDEMA 7 0.0040
395 HISTOPLASMOSIS 7 0.0040
396 ACUTE PULMONARY OEDEMA 22 0.0039
397 PNEUMONIA PSEUDOMONAL 6 0.0039
398 SEPTIC SHOCK 170 0.0039
399 NEPHRITIS 13 0.0039
400 ACUTE LYMPHOCYTIC LEUKAEMIA 11 0.0039
401 NEUTROPENIC COLITIS 8 0.0039
402 HYPOALBUMINAEMIA 30 0.0039
403 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 19 0.0038
404 MUCOSAL INFLAMMATION 99 0.0038
405 JC VIRUS INFECTION 6 0.0037
406 CD4 LYMPHOCYTES DECREASED 8 0.0037
407 METASTATIC NEOPLASM 16 0.0037
408 ERYTHEMA NODOSUM 13 0.0037
409 THROMBOTIC THROMBOCYTOPENIC PURPURA 13 0.0037
410 MYELODYSPLASTIC SYNDROME 53 0.0037
411 BILIARY TRACT DISORDER 5 0.0036
412 VENTRICULAR HYPERTROPHY 9 0.0036
413 PULMONARY ALVEOLAR HAEMORRHAGE 20 0.0036
414 CLOSTRIDIAL INFECTION 12 0.0035
415 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 7 0.0035
416 HAEMODYNAMIC INSTABILITY 27 0.0035
417 MYELOSUPPRESSION 127 0.0035
418 PNEUMATOSIS INTESTINALIS 10 0.0035
419 IMMUNE THROMBOCYTOPENIA 16 0.0035
420 HEPATITIS B 21 0.0035
421 MYCOBACTERIAL INFECTION 6 0.0035
422 RETINITIS 6 0.0035
423 GRANULOMA 12 0.0035
424 RENAL HAEMORRHAGE 7 0.0034
425 URINE OUTPUT DECREASED 30 0.0034
426 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 13 0.0034
427 GUILLAIN-BARRE SYNDROME 16 0.0033
428 PNEUMOPERITONEUM 6 0.0032
429 B-CELL LYMPHOMA 11 0.0032
430 ORGANISING PNEUMONIA 16 0.0032
431 NEPHROTIC SYNDROME 22 0.0032
432 ACUTE MYELOID LEUKAEMIA 50 0.0032
433 RENAL TUBULAR DISORDER 9 0.0032
434 CYTOKINE RELEASE SYNDROME 64 0.0032
435 HYPOPROTEINAEMIA 6 0.0032
436 PROTEINURIA 59 0.0031
437 HYPERBILIRUBINAEMIA 32 0.0031
438 LYMPHADENOPATHY 109 0.0031
439 BLOOD CREATININE INCREASED 201 0.0031
440 BLOOD BILIRUBIN INCREASED 83 0.0031
441 CELL DEATH 6 0.0030
442 AZOTAEMIA 12 0.0030
443 HYPERLACTACIDAEMIA 8 0.0030
444 NEPHROGENIC SYSTEMIC FIBROSIS 9 0.0030
445 CORONARY ARTERY THROMBOSIS 6 0.0030
446 UROSEPSIS 27 0.0029
447 HYPERURICAEMIA 12 0.0029
448 ENCEPHALITIS 20 0.0029
449 LYMPHADENITIS 7 0.0029
450 LUNG CONSOLIDATION 8 0.0029
451 STAPHYLOCOCCAL INFECTION 94 0.0028
452 BLOOD LACTATE DEHYDROGENASE INCREASED 45 0.0028
453 HYPERPYREXIA 12 0.0028
454 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
455 STUPOR 9 0.0028
456 ENTEROCOLITIS 16 0.0028
457 PERICARDIAL HAEMORRHAGE 6 0.0027
458 CARDIAC TAMPONADE 13 0.0027
459 CYTOPENIA 33 0.0027
460 CREPITATIONS 8 0.0027
461 BONE MARROW TRANSPLANT 5 0.0026
462 DRUG LEVEL ABOVE THERAPEUTIC 12 0.0026
463 DENGUE FEVER 6 0.0026
464 NEUROLOGICAL DECOMPENSATION 6 0.0026
465 BRAIN DEATH 8 0.0026
466 LARGE INTESTINAL ULCER 7 0.0026
467 RESPIRATORY FAILURE 187 0.0026
468 THROMBOCYTOPENIA 281 0.0025
469 PULMONARY OEDEMA 112 0.0025
470 RENAL IMPAIRMENT 210 0.0025
471 ACUTE RESPIRATORY FAILURE 48 0.0025
472 DEVICE RELATED SEPSIS 5 0.0025
473 SEPSIS 275 0.0025
474 COAGULOPATHY 41 0.0025
475 LYMPHOCYTE COUNT INCREASED 8 0.0024
476 AUTOIMMUNE HEPATITIS 17 0.0024
477 SUSPECTED OFF LABEL USE 11 0.0024
478 HERPES VIRUS INFECTION 14 0.0024
479 TACHYARRHYTHMIA 6 0.0024
480 STRIDOR 7 0.0024
481 METASTASES TO LYMPH NODES 16 0.0024
482 TACHYPNOEA 32 0.0024
483 PULMONARY TUBERCULOSIS 10 0.0023
484 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 24 0.0023
485 BRONCHOPNEUMONIA 8 0.0023
486 ABSCESS INTESTINAL 5 0.0023
487 NO THERAPEUTIC RESPONSE 28 0.0023
488 FIBROSIS 7 0.0023
489 FUNGAL SKIN INFECTION 9 0.0022
490 HYPERAMMONAEMIA 11 0.0022
491 CORONARY ARTERY STENOSIS 11 0.0022
492 DRUG RESISTANCE 56 0.0022
493 GASTROINTESTINAL INFLAMMATION 17 0.0022
494 PERICARDIAL EFFUSION 50 0.0022
495 LARGE INTESTINE PERFORATION 15 0.0022
496 LIVER ABSCESS 7 0.0022
497 HEPATITIS C 26 0.0022
498 SQUAMOUS CELL CARCINOMA 20 0.0021
499 ACUTE HEPATIC FAILURE 29 0.0021
500 ASCITES 62 0.0021
501 TOXIC EPIDERMAL NECROLYSIS 32 0.0021
502 SHOCK 48 0.0021
503 WOUND DEHISCENCE 7 0.0021
504 RALES 12 0.0021
505 HEPATOTOXICITY 46 0.0021
506 DISEASE RECURRENCE 98 0.0021
507 GASTROINTESTINAL NECROSIS 6 0.0021
508 DRUG LEVEL INCREASED 34 0.0021
509 DIALYSIS 29 0.0020
510 ENCEPHALOPATHY 50 0.0020
511 TUBULOINTERSTITIAL NEPHRITIS 38 0.0020
512 RENAL FAILURE ACUTE 86 0.0020
513 HYPOMAGNESAEMIA 28 0.0020
514 OESOPHAGEAL CANDIDIASIS 8 0.0020
515 HEPATITIS ACUTE 13 0.0020
516 LUNG DISORDER 98 0.0020
517 INTESTINAL ISCHAEMIA 11 0.0020
518 FLUID OVERLOAD 29 0.0020
519 MUSCLE CONTRACTIONS INVOLUNTARY 7 0.0020
520 SQUAMOUS CELL CARCINOMA OF SKIN 12 0.0020
521 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
522 KERATITIS 6 0.0020
523 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
524 PYREXIA 681 0.0020
525 DRUG LEVEL DECREASED 20 0.0020
526 HYPERTHERMIA 15 0.0020
527 ANGIOPATHY 11 0.0020
528 ABDOMINAL INFECTION 5 0.0020
529 AUTOIMMUNE DISORDER 19 0.0019
530 HYPERKALAEMIA 68 0.0019
531 LUNG INFECTION 30 0.0019
532 TONSILLITIS 10 0.0019
533 ORAL HERPES 37 0.0019
534 PRE-ECLAMPSIA 9 0.0019
535 HEPATITIS B REACTIVATION 6 0.0019
536 HEPATIC FUNCTION ABNORMAL 70 0.0019
537 FOOD POISONING 10 0.0019
538 LYMPHOCYTE COUNT DECREASED 33 0.0019
539 HYPERCALCAEMIA 23 0.0019
540 PORTAL VEIN THROMBOSIS 6 0.0019
541 HEPATIC LESION 8 0.0018
542 HYPOXIA 65 0.0018
543 ACIDOSIS 14 0.0018
544 HYPERVOLAEMIA 9 0.0018
545 IMMUNOSUPPRESSION 16 0.0018
546 VISUAL FIELD DEFECT 13 0.0018
547 PERITONITIS 37 0.0018
548 COVID-19 PNEUMONIA 21 0.0018
549 CACHEXIA 9 0.0017
550 HEPATIC FIBROSIS 6 0.0017
551 SKIN PAPILLOMA 7 0.0017
552 BRAIN OEDEMA 22 0.0017
553 FUNGAL INFECTION 58 0.0017
554 SKIN NECROSIS 9 0.0017
555 ASPARTATE AMINOTRANSFERASE INCREASED 92 0.0017
556 NEUTROPENIA 235 0.0017
557 POST PROCEDURAL COMPLICATION 33 0.0017
558 PULMONARY TOXICITY 12 0.0017
559 ALANINE AMINOTRANSFERASE INCREASED 104 0.0017
560 LIVER FUNCTION TEST ABNORMAL 49 0.0017
561 CHOLECYSTITIS 20 0.0017
562 ODYNOPHAGIA 10 0.0017
563 ACUTE KIDNEY INJURY 254 0.0017
564 ATRIOVENTRICULAR BLOCK COMPLETE 11 0.0016
565 DERMATITIS ACNEIFORM 10 0.0016
566 VASCULITIS 19 0.0016
567 DUODENITIS 5 0.0016
568 ATRIAL FLUTTER 13 0.0016
569 LUNG INFILTRATION 14 0.0016
570 TOXIC ENCEPHALOPATHY 8 0.0016
571 HAEMATOTOXICITY 15 0.0016
572 RESPIRATORY RATE INCREASED 14 0.0016
573 CHOLESTASIS 30 0.0016
574 DEVICE RELATED INFECTION 24 0.0016
575 ATELECTASIS 15 0.0016
576 WOUND INFECTION 17 0.0016
577 LEUKOCYTOSIS 28 0.0015
578 FAILURE TO THRIVE 8 0.0015
579 TRANSAMINASES INCREASED 34 0.0015
580 CIRCULATORY COLLAPSE 26 0.0015
581 GRAND MAL CONVULSION 14 0.0015
582 PLEURISY 9 0.0015
583 MULTIPLE MYELOMA 7 0.0015
584 MOUTH HAEMORRHAGE 11 0.0015
585 HEPATIC FAILURE 45 0.0015
586 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
587 CEREBRAL HAEMORRHAGE 53 0.0015
588 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 12 0.0015
589 HEPATOMEGALY 14 0.0014
590 CLOSTRIDIUM DIFFICILE INFECTION 31 0.0014
591 HAEMORRHAGIC STROKE 11 0.0014
592 RETINAL HAEMORRHAGE 10 0.0014
593 GENERALISED TONIC-CLONIC SEIZURE 23 0.0014
594 DRUG SPECIFIC ANTIBODY PRESENT 9 0.0014
595 LIVER DISORDER 61 0.0014
596 TACHYCARDIA 122 0.0014
597 PHLEBITIS 7 0.0014
598 INFECTION 195 0.0013
599 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
600 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
601 HEMIPARESIS 22 0.0013
602 CHOLANGITIS 8 0.0013
603 MOUTH ULCERATION 27 0.0013
604 YELLOW SKIN 6 0.0013
605 VENTRICULAR TACHYCARDIA 21 0.0013
606 LEUKAEMIA 12 0.0013
607 PLATELET COUNT DECREASED 135 0.0013
608 DIVERTICULUM 9 0.0013
609 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
610 NECROSIS 7 0.0013
611 INTESTINAL PERFORATION 14 0.0012
612 HYPOTENSION 250 0.0012
613 FISTULA 14 0.0012
614 SKIN LESION 34 0.0012
615 ORAL DISORDER 9 0.0012
616 NEUROLOGICAL SYMPTOM 7 0.0012
617 HYPOPHOSPHATAEMIA 9 0.0012
618 ANAPHYLACTOID REACTION 5 0.0012
619 CORONAVIRUS INFECTION 8 0.0012
620 ABDOMINAL TENDERNESS 6 0.0012
621 INFUSION RELATED REACTION 80 0.0012
622 OEDEMA 65 0.0012
623 SPLENOMEGALY 14 0.0012
624 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
625 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 65 0.0012
626 C-REACTIVE PROTEIN INCREASED 43 0.0012
627 DIARRHOEA HAEMORRHAGIC 11 0.0012
628 DRUG TOXICITY 16 0.0012
629 OXYGEN SATURATION DECREASED 66 0.0012
630 THERAPEUTIC RESPONSE DECREASED 71 0.0012
631 STEVENS-JOHNSON SYNDROME 26 0.0012
632 TYPE 1 DIABETES MELLITUS 7 0.0012
633 METABOLIC ACIDOSIS 37 0.0012
634 LARGE INTESTINE POLYP 8 0.0012
635 MENTAL STATUS CHANGES 32 0.0012
636 HYPERTRANSAMINASAEMIA 8 0.0011
637 PETECHIAE 12 0.0011
638 CHILLS 134 0.0011
639 PNEUMONITIS 31 0.0011
640 BLOOD UREA INCREASED 19 0.0011
641 ABDOMINAL ABSCESS 5 0.0011
642 BLOOD CREATINE INCREASED 5 0.0011
643 ILEUS 14 0.0011
644 INFUSION SITE EXTRAVASATION 7 0.0011
645 NORMAL NEWBORN 6 0.0011
646 PLEURAL EFFUSION 67 0.0011
647 HYPERGLYCAEMIA 40 0.0011
648 NONSPECIFIC REACTION 6 0.0011
649 ANAPHYLACTIC SHOCK 28 0.0011
650 PANCREATITIS ACUTE 24 0.0011
651 PRODUCT USE IN UNAPPROVED INDICATION 264 0.0011
652 ORAL CANDIDIASIS 14 0.0011
653 CHOLECYSTITIS ACUTE 6 0.0011
654 TENDERNESS 11 0.0011
655 ACUTE MYOCARDIAL INFARCTION 31 0.0011
656 HAEMATURIA 36 0.0011
657 CARDIAC FAILURE ACUTE 7 0.0010
658 CARDIOGENIC SHOCK 15 0.0010
659 RENAL FAILURE CHRONIC 8 0.0010
660 BRONCHIECTASIS 7 0.0010
661 POSTOPERATIVE WOUND INFECTION 7 0.0010
662 POST PROCEDURAL HAEMORRHAGE 12 0.0010
663 HERPES ZOSTER 59 0.0010
664 HYPOVOLAEMIA 6 0.0010
665 HYPOPHAGIA 26 0.0010
666 RENAL FAILURE 135 0.0010
667 MYOCLONUS 12 0.0010
668 PROTHROMBIN TIME PROLONGED 6 0.0010
669 COLITIS 38 0.0010
670 THERAPY NON-RESPONDER 45 0.0010
671 HEARING IMPAIRED 6 0.0010
672 PAPULE 7 0.0010
673 INTERSTITIAL LUNG DISEASE 48 0.0010
674 URINARY TRACT INFECTION 169 0.0010
675 STOMATITIS 60 0.0010
676 NEUTROPENIC SEPSIS 7 0.0010
677 METASTASES TO LIVER 17 0.0010
678 ANAEMIA 184 0.0010
679 APPENDICITIS 9 0.0010
680 METASTASES TO LUNG 11 0.0010
681 RASH MACULO-PAPULAR 21 0.0009
682 PREMATURE DELIVERY 15 0.0009
683 CEREBRAL INFARCTION 23 0.0009
684 WHITE BLOOD CELL COUNT DECREASED 102 0.0009
685 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
686 HAEMORRHAGE INTRACRANIAL 14 0.0009
687 PROCEDURAL COMPLICATION 7 0.0009
688 WALKING AID USER 6 0.0009
689 TUMOUR LYSIS SYNDROME 8 0.0009
690 VENTRICULAR FIBRILLATION 10 0.0009
691 MENINGITIS 6 0.0009
692 CARDIOMEGALY 11 0.0009
693 PERICARDITIS 15 0.0009
694 HYPOKALAEMIA 41 0.0009
695 ANAPHYLACTIC REACTION 49 0.0009
696 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
697 UVEITIS 12 0.0009
698 SUBARACHNOID HAEMORRHAGE 9 0.0009
699 PNEUMOTHORAX 14 0.0009
700 CARDIAC ARREST 71 0.0009
701 HAEMATOCRIT DECREASED 17 0.0009
702 HAEMOGLOBIN DECREASED 88 0.0009
703 NEPHROPATHY 8 0.0009
704 PNEUMONIA 277 0.0009
705 HYPERTENSION 181 0.0009
706 FLANK PAIN 8 0.0009
707 HEPATOCELLULAR INJURY 12 0.0008
708 BRONCHOSPASM 12 0.0008
709 DRUG INTOLERANCE 81 0.0008
710 PARALYSIS 12 0.0008
711 DIABETIC KETOACIDOSIS 20 0.0008
712 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
713 PERITONITIS BACTERIAL 8 0.0008
714 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
715 HAEMOPTYSIS 22 0.0008
716 NEUTROPHIL COUNT DECREASED 32 0.0008
717 OFF LABEL USE 685 0.0008
718 HELICOBACTER INFECTION 8 0.0008
719 EJECTION FRACTION DECREASED 12 0.0008
720 END STAGE RENAL DISEASE 14 0.0008
721 BLOOD ALBUMIN DECREASED 6 0.0008
722 CELLULITIS 38 0.0008
723 CONVULSION 43 0.0008
724 ARTERIOSCLEROSIS 7 0.0007
725 HEPATITIS 19 0.0007
726 EOSINOPHILIA 13 0.0007
727 ABNORMAL LOSS OF WEIGHT 5 0.0007
728 HICCUPS 6 0.0007
729 MELAENA 16 0.0007
730 TREATMENT FAILURE 60 0.0007
731 HEMIPLEGIA 6 0.0007
732 BLOOD PRESSURE DECREASED 47 0.0007
733 SINUS TACHYCARDIA 10 0.0007
734 MYOCARDIAL ISCHAEMIA 8 0.0007
735 OVARIAN CYST 7 0.0007
736 HAEMATOMA 18 0.0007
737 DERMATITIS BULLOUS 5 0.0007
738 GASTROENTERITIS 10 0.0007
739 PULMONARY CONGESTION 9 0.0007
740 TEMPERATURE INTOLERANCE 7 0.0007
741 TOOTH DISORDER 15 0.0007
742 CARDIAC FAILURE 54 0.0007
743 COMA 31 0.0007
744 SKIN CANCER 14 0.0006
745 GASTROINTESTINAL HAEMORRHAGE 54 0.0006
746 GASTRITIS 17 0.0006
747 DIABETES MELLITUS 49 0.0006
748 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
749 TOXICITY TO VARIOUS AGENTS 107 0.0006
750 DEPRESSED LEVEL OF CONSCIOUSNESS 25 0.0006
751 JAUNDICE 17 0.0006
752 INTERNATIONAL NORMALISED RATIO INCREASED 18 0.0006
753 SLEEP APNOEA SYNDROME 12 0.0006
754 ABSCESS 10 0.0006
755 DYSURIA 23 0.0006
756 METASTASES TO CENTRAL NERVOUS SYSTEM 8 0.0006
757 LACTIC ACIDOSIS 20 0.0006
758 ABNORMAL FAECES 5 0.0006
759 NEOPLASM 7 0.0006
760 BRADYCARDIA 32 0.0006
761 HYPOTONIA 6 0.0006
762 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 14 0.0006
763 BODY TEMPERATURE INCREASED 12 0.0006
764 DEHYDRATION 78 0.0006
765 HYPOCALCAEMIA 11 0.0006
766 ADRENAL INSUFFICIENCY 7 0.0006
767 ATRIAL FIBRILLATION 56 0.0006
768 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
769 SMALL INTESTINAL OBSTRUCTION 7 0.0006
770 DRUG INTERACTION 89 0.0006
771 ALTERED STATE OF CONSCIOUSNESS 12 0.0006
772 HAEMATEMESIS 14 0.0006
773 CARDIO-RESPIRATORY ARREST 23 0.0005
774 OESOPHAGITIS 6 0.0005
775 METASTASES TO BONE 9 0.0005
776 ASPIRATION 6 0.0005
777 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
778 RESPIRATORY DISORDER 16 0.0005
779 APHASIA 16 0.0005
780 GASTRIC ULCER 10 0.0005
781 OEDEMA PERIPHERAL 64 0.0005
782 ABDOMINAL PAIN 121 0.0005
783 DISEASE PROGRESSION 61 0.0005
784 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
785 CYSTITIS 16 0.0005
786 POLYNEUROPATHY 6 0.0005
787 HEPATIC ENZYME INCREASED 34 0.0005
788 THYROID CANCER 6 0.0005
789 HYPONATRAEMIA 28 0.0005
790 CORONARY ARTERY DISEASE 15 0.0005
791 RENAL DISORDER 23 0.0005
792 DEEP VEIN THROMBOSIS 32 0.0005
793 OSTEONECROSIS 16 0.0005
794 CARDIOMYOPATHY 7 0.0005
795 DIARRHOEA 305 0.0005
796 HEPATIC CYTOLYSIS 6 0.0005
797 PULMONARY MASS 7 0.0005
798 MYDRIASIS 6 0.0005
799 COVID-19 81 0.0005
800 DELIRIUM 16 0.0005
801 IMPAIRED HEALING 15 0.0005
802 LYMPHOMA 7 0.0005
803 THERAPY PARTIAL RESPONDER 7 0.0004
804 GASTROINTESTINAL DISORDER 40 0.0004
805 INTENTIONAL PRODUCT USE ISSUE 39 0.0004
806 CYANOSIS 7 0.0004
807 OSTEOMYELITIS 8 0.0004
808 CARDIAC FAILURE CONGESTIVE 35 0.0004
809 RESPIRATORY ARREST 12 0.0004
810 BLOOD POTASSIUM INCREASED 7 0.0004
811 ELECTROLYTE IMBALANCE 5 0.0004
812 HEPATIC STEATOSIS 8 0.0004
813 VIRAL INFECTION 14 0.0004
814 DYSKINESIA 17 0.0004
815 FACE OEDEMA 7 0.0004
816 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
817 BURSITIS 5 0.0004
818 HAEMORRHAGE 43 0.0004
819 SEIZURE 47 0.0004
820 NEUROTOXICITY 7 0.0004
821 PANCREATITIS 21 0.0004
822 ABDOMINAL PAIN LOWER 10 0.0004
823 DRUG INEFFECTIVE 521 0.0004
824 ISCHAEMIC STROKE 7 0.0004
825 NEOPLASM MALIGNANT 26 0.0004
826 ANOREXIA 5 0.0004
827 TREMOR 64 0.0004
828 RESPIRATORY TRACT INFECTION 10 0.0004
829 TREATMENT NONCOMPLIANCE 21 0.0004
830 ADVERSE REACTION 5 0.0004
831 AGRANULOCYTOSIS 7 0.0004
832 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
833 LABORATORY TEST ABNORMAL 11 0.0004
834 LIVER INJURY 9 0.0004
835 CHOLELITHIASIS 12 0.0004
836 CORONARY ARTERY OCCLUSION 5 0.0004
837 COLITIS ULCERATIVE 16 0.0004
838 CARDIOVASCULAR DISORDER 9 0.0004
839 DRUG-INDUCED LIVER INJURY 11 0.0004
840 RED BLOOD CELL COUNT DECREASED 10 0.0003
841 NECK PAIN 19 0.0003
842 PULMONARY HYPERTENSION 7 0.0003
843 BLOOD PRESSURE FLUCTUATION 8 0.0003
844 GASTROENTERITIS VIRAL 6 0.0003
845 INFLUENZA 37 0.0003
846 INFLAMMATION 17 0.0003
847 CONFUSIONAL STATE 52 0.0003
848 HEPATIC CIRRHOSIS 6 0.0003
849 DECREASED APPETITE 74 0.0003
850 ARRHYTHMIA 15 0.0003
851 DYSPHAGIA 30 0.0003
852 FLUID RETENTION 16 0.0003
853 VOMITING 147 0.0003
854 EAR PAIN 6 0.0003
855 EXPOSURE DURING PREGNANCY 19 0.0003
856 RENAL INJURY 9 0.0003
857 CHRONIC KIDNEY DISEASE 23 0.0003
858 PRESCRIBED UNDERDOSE 6 0.0003
859 PREMATURE BABY 9 0.0003
860 NEUROPATHY PERIPHERAL 28 0.0003
861 PRODUCT PRESCRIBING ERROR 7 0.0003
862 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
863 INTESTINAL OBSTRUCTION 11 0.0003
864 HEART RATE INCREASED 28 0.0003
865 PNEUMONIA ASPIRATION 7 0.0003
866 LIVER FUNCTION TEST INCREASED 6 0.0003
867 ANGINA PECTORIS 8 0.0003
868 PRODUCTIVE COUGH 13 0.0003
869 UNRESPONSIVE TO STIMULI 7 0.0003
870 SKIN ULCER 7 0.0003
871 DYSPNOEA 148 0.0003
872 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
873 PALLOR 7 0.0003
874 RASH 112 0.0003
875 COUGH 72 0.0003
876 NERVOUS SYSTEM DISORDER 8 0.0003
877 CHEST DISCOMFORT 26 0.0003
878 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
879 THROMBOSIS 20 0.0002
880 PAIN IN JAW 7 0.0002
881 BLINDNESS 10 0.0002
882 CONDITION AGGRAVATED 74 0.0002
883 NAUSEA 191 0.0002
884 URINARY RETENTION 8 0.0002
885 PSYCHOTIC DISORDER 7 0.0002
886 MEDICATION ERROR 13 0.0002
887 ARTHRALGIA 97 0.0002
888 RASH GENERALISED 6 0.0002
889 AGITATION 17 0.0002
890 DIPLOPIA 6 0.0002
891 BRONCHITIS 17 0.0002
892 HEART RATE DECREASED 8 0.0002
893 WEIGHT DECREASED 63 0.0002
894 PULMONARY EMBOLISM 21 0.0002
895 MYALGIA 36 0.0002
896 RASH ERYTHEMATOUS 10 0.0002
897 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
898 WHEEZING 12 0.0002
899 MYOCARDIAL INFARCTION 35 0.0002
900 DRUG ADMINISTRATION ERROR 6 0.0002
901 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
902 RHABDOMYOLYSIS 8 0.0002
903 EPISTAXIS 14 0.0002
904 RECTAL HAEMORRHAGE 8 0.0002
905 SINUSITIS 19 0.0002
906 MENTAL DISORDER 8 0.0002
907 ASTHENIA 67 0.0002
908 DISORIENTATION 7 0.0002
909 BLOOD PRESSURE INCREASED 27 0.0002
910 UNEVALUABLE EVENT 13 0.0002
911 BONE PAIN 10 0.0002
912 PRODUCT USE ISSUE 32 0.0002
913 ERYTHEMA 35 0.0002
914 DISTURBANCE IN ATTENTION 9 0.0002
915 HAEMATOCHEZIA 9 0.0002
916 OROPHARYNGEAL PAIN 15 0.0002
917 HYPERSENSITIVITY 30 0.0002
918 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
919 ABDOMINAL DISTENSION 16 0.0002
920 WEIGHT INCREASED 34 0.0002
921 CHEST PAIN 28 0.0002
922 COGNITIVE DISORDER 7 0.0001
923 MUSCULAR WEAKNESS 17 0.0001
924 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
925 ACNE 11 0.0001
926 HYPOGLYCAEMIA 7 0.0001
927 BLISTER 8 0.0001
928 HEADACHE 89 0.0001
929 LETHARGY 8 0.0001
930 URTICARIA 23 0.0001
931 DYSPHONIA 8 0.0001
932 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
933 MUSCULOSKELETAL PAIN 7 0.0001
934 SPEECH DISORDER 7 0.0001
935 DYSPNOEA EXERTIONAL 5 0.0001
936 ARTHRITIS 10 0.0001
937 LOSS OF CONSCIOUSNESS 16 0.0001
938 ABORTION SPONTANEOUS 5 0.0001
939 DEATH 107 0.0001
940 MALAISE 54 0.0001
941 ADVERSE DRUG REACTION 11 0.0001
942 NASAL CONGESTION 7 0.0001
943 CONSTIPATION 25 0.0001
944 INJURY 8 0.0001
945 PAIN IN EXTREMITY 33 0.0001
946 BACK PAIN 25 0.0001
947 SWELLING 10 0.0001
948 BLOOD GLUCOSE DECREASED 5 0.0001
949 PRURITUS 40 0.0001
950 PRODUCT QUALITY ISSUE 14 0.0001
951 PRODUCT STORAGE ERROR 9 0.0001
952 INSOMNIA 27 0.0001
953 BLOOD GLUCOSE INCREASED 19 0.0001
954 PAIN 61 0.0001
955 ASTHMA 11 0.0001
956 VISION BLURRED 13 0.0001
957 HYPOAESTHESIA 14 0.0001
958 RHINORRHOEA 6 0.0001
959 DRUG EFFECT DECREASED 5 0.0001
960 GAIT DISTURBANCE 17 0.0001
961 ABDOMINAL PAIN UPPER 18 0.0001
962 BLADDER CANCER 5 0.0001
963 DYSPEPSIA 8 0.0001
964 RHEUMATOID ARTHRITIS 9 0.0001
965 HYPERHIDROSIS 10 0.0001
966 ABDOMINAL DISCOMFORT 13 0.0001
967 ADVERSE EVENT 7 0.0001
968 JOINT SWELLING 9 0.0001
969 SOMNOLENCE 15 0.0001
970 FATIGUE 57 0.0001
971 VISUAL IMPAIRMENT 9 0.0001
972 BURNING SENSATION 5 0.0001
973 ALOPECIA 14 0.0001
974 BALANCE DISORDER 6 0.0001
975 FLUSHING 7 0.0001
976 PALPITATIONS 8 0.0001
977 ANXIETY 19 0.0001
978 NO ADVERSE EVENT 12 0.0001
979 FALL 22 0.0001
980 INCORRECT DOSE ADMINISTERED 15 0.0001
981 CARDIAC DISORDER 6 0.0001
982 DIZZINESS 29 0.0001
983 OVERDOSE 12 0.0001
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
985 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
986 NASOPHARYNGITIS 10 0.0001
987 PERIPHERAL SWELLING 7 0.0000
988 DEPRESSION 10 0.0000
989 MUSCLE SPASMS 8 0.0000
990 CEREBROVASCULAR ACCIDENT 5 0.0000